Investing.com -- Bright Minds Biosciences (NASDAQ:DRUG) stock rose 5% after the clinical-stage biotechnology company announced positive topline results from its Phase 2 BREAKTHROUGH trial for BMB-101 ...

Shares of Bright Minds Biosciences rose after the company released positive topline results from its phase two trial of a treatment for patients with drug-resistant Absence Seizures and Developmental ...

After experiencing a seizure, children were seen by a neurology epilepsy specialist a median of 6 days after referral to the first-seizure clinic. HealthDay News — Children referred to a first seizure ...

A seizure (SEE-zhur) is unusual electrical activity in the brain. Normally, electrical activity in the brain involves neurons (nerve cells) in different areas sending signals at different times.

The award recognizes Dr. Kuperman’s pioneering work in developing the Eysz™ HV Recorder, a novel device designed to standardize the hyperventilation procedure and collect objective video evidence to ...

BTIG initiated coverage on Bright Minds Biosciences Inc. (NASDAQ:DRUG), a clinical-stage company focused on neurological and psychiatric disorders. Investment in Bright Minds is based on the ...

The first sign that Lynda Smith had epilepsy happened almost 20 years ago while she was driving down Interstate 30, near Hope, Arkansas, on her way to work at an HVAC installer. First her right leg ...